Pharmacy pilot evaluation revealed An assessment of Victoria’s program reveals its impact on GP services, its popularity, and patient feedback, as the RACGP’s concerns about the nationwide trend remain.
COVID-19 vaccine support items coming to an end From 1 July, the MBS items for vaccine suitability assessments, and associated items, introduced during the pandemic, will cease.
TGA warns of ‘possible but rare’ RSV vaccines risk Product Information for Arexvy and Abrysvo has been updated to reflect a low risk of Guillain-Barre Syndrome following vaccination.
‘A step backwards’: Another pharmacy pilot made permanent The initiative continues to cement itself into Australian healthcare, with a Victorian pilot both expanded and made permanent, but the RACGP warns of compromised patient safety.
Queensland pharmacy pilot reaches training milestone One hundred community pharmacists are reportedly fully trained and authorised to participate, but the RACGP says it ‘rings alarm bells’.
Fresh push to turn around ‘dire’ flu vaccination rate The RACGP has joined calls to boost influenza vaccinations as cases continue to climb, with increases seen across all Australian jurisdictions.
RSV vaccine approved for use in at-risk over-50s The new TGA approval allows access to the Arexvy vaccine for at-risk adults aged 50–59, expanding the previous indication.
GPs remain the frontline in vaccination With the WHO warning global immunisation gains are at risk, an RACGP expert says GPs are best placed to get vaccination rates up.
Using same arm for vaccination boosts antibody response: Study New Australian research suggests that using the same arm for vaccine boosters could trigger a more rapid immune response.
Shingles vaccine linked to dementia risk reduction The new research found those vaccinated had their risk of new dementia diagnoses reduced by 20% over seven years.